Structure prediction and R115866 binding study of human CYP26A1: homology modelling, fold recognition, molecular docking and MD simulations

Abstract

Two three-dimensional (3D) models of human cytochrome P450 26A1 (CYP26A1) were constructed using the programs Modeller and Sybyl-GeneFold, respectively. After refinement by molecular mechanics and molecular dynamics (MD) simulations, the two models were validated by structure analysis-validation online server. Subsequently, a flexible docking study was performed on the model constructed by GeneFold with the potent and specific inhibitor R115866 to examine the enzyme–inhibitor interactions. From the docking results, we can see R115866 interacts with amino acid residues at the active site by multiple hydrophobic interactions including the side chains of His111, Trp112, Ser115, Val116, Leu125, Ser126, Leu221, Phe222, Glu296, Phe299, Gly300, Glu303, Thr304, Pro371 and the cofactor heme. Trp112 and Thr304 form hydrogen bonds with R115866 and play important roles in stabilising the complex. This constructed CYP26A1 model may provide an opportunity to understand the action mode of the enzyme and could be useful in designing novel retinoic acid metabolism blocking agents (RAMBAs).

Keywords:

• molecular modelling
• CYP26A1
• molecular dynamics
• docking
• R115866

Acknowledgement

The MD simulations were carried out on the Sunway supercomputer platform at Beijing Institute of Pharmacology and Toxicology. We also acknowledge Professor Song Li for his support.

Notes

^1. http://www.expasy.org/tools/blast

^2. SYBYL 6.91; Tripos Inc. (1699 South Hanley Road, St Louis, MO 63144, USA); http://www.tripos.com

^3. http://nihserver.mbi.ucla.edu/SAVS/